semaglutide news oct 26 2025 october Semaglutide 2.4 mg Clinical Outcomes in Patients with Obesity or Overweight: A Real-World Retrospective Comparative Cohort Study Business | Danish drugmaker Novo

While Im a long-time advocate of people taking on consumer-style habits for health and well-being, as a health economist and long-time analyst of and advisor to the ecosystem of stakeholders, Ive always been a realist about the shortcomings of assuming health care consumerism was a unified field theory for all health citizens in the U.S

In a development that could reshape diabetes care in Canada, the path has been cleared for generic versions of Ozempic and Wegovy to enter the Canadian market in 2026

Understanding your genetic predispositions and biomarkers can help inform a more personalized safety conversa

Explore how Leger combines TRT with GLP-1 weight loss medication to support energy, muscle mass and body composition

See who qualifies

Even though you havent lost much weight yet, your heart is already much safer.